In Clec9a-/- mice, the tumor volume was not significantly different between the CBP-12-OVA and normal saline groups, indicating that CBP-12-OVA specifically targets Clec9a in vivo and the antitumor effects are dependent on Clec9a (Figure S7). This evidence concerns the gene SPRR2A and neoplasm.